Preliminary Agenda |
Saturday, April
21, 2007
|
|
08:30 |
Welcome and Introduction |
Thomas Parker |
|
I New Strategies in High Risk Prevention |
Chair:
Stuart Hutchinson |
08:40 |
Implications of the Evidence-Based Canadian
Obesity Clinical Practice Guidelines to the Practicing Cardiologist |
|
08:55 |
Aggressive Interventions: From
pre-diabetes to diabetes - The role of rosiglitazone
|
Amir
Hanna |
09:10 |
Global Risk Assessment: The
New Math 1+1 = 4 ! |
Beth
Abramson |
09:25 |
The Who, When and How of Imaging in the High Risk
Asymptomatic Patient |
Michael Freeman |
09:40 |
Case Presentation / Panel Discussion |
|
10:10 - 10:40 |
|
|
............................................................................................................................................ |
10:40 |
II Clinical
Trials In The Past Year That Impact On My Practice |
Chair:
Abdul Al-Hesayen |
............................................................................................................................................ |
|
III What
to do When the Plaque Ruptures |
Chair:
Robert Chisholm |
11:10 |
The Acute Coronary Syndrome
(ACS) Top Ten |
Shaun
Goodman |
11:25 |
DES: Benefit or Hazard |
Michael
Kutryk |
11:40 |
The Risk-Management Paradox: Are we really selecting the right
patients? |
Andrew Yan |
11:55 |
Case Presentation / Panel Discussion |
|
12:30 - 13:30 |
|
|
............................................................................................................................................ |
|
IV Improving Outcomes
in Complex patients |
Chair:Howard
Leong-Poi |
13:30 |
Acute Heart Failure: New Evidence,
New Guidelines |
Gordon Moe
|
13:45 |
Devices for Dummies |
Victoria Korley
|
14:00 |
What’s new in Hypertension? |
Juan Carlos
Monge
|
14:15 |
The Chronic Vascular Disease Management Marketplace: But who is
ihe investor? |
David Alter
|
14:30 |
Case Presentation / Panel Discussion |
|
............................................................................................................................................ |
|
V Debate |
Chair:Thomas
Parker |
15:00 |
A Cardiologist’s Perspective: NSAID’s,
including COX-2 inhibitors, are not safe |
Protagonist:
David Fitchett
Antagonist:
Anatoly Langer |
............................................................................................................................................ |
16:00 |
Conclusion and Cocktail
Reception
|
|
|